文献速递临床试验与 GCP

测试经颅直流电刺激对语义性痴呆的治疗效果:一项双盲、假刺激对照、随机临床试验

Testing the therapeutic effects of transcranial direct current stimulation (tDCS) in semantic dementia: a double blind, sham controlled, randomized clinical trial.
PubMed 文献 · Trials · 2019-11-20

STIM-SD 是一项双盲、假刺激对照、随机临床试验,计划纳入 60 例语义性痴呆患者,分为左侧阳极、右侧阴极和假刺激三组,每日进行 10 天经颅直流电刺激,并在基线、第 3 天、第 2 周和第 4 个月评估语言和语义功能,同时利用 FDG-PET、rs-fMRI、T1 加权成像和 DTI 探索影像生物标志物;另招募 20 名健康对照提供常模。研究旨在评估该刺激方案对语言/语义障碍的疗效,并探索其时间进程和神经可塑性机制。

要点

  • 语义性痴呆主要累及左前颞叶,目前尚无验证有效的治疗。
  • 该试验采用双盲、假刺激对照、随机设计,计划纳入 60 例患者和 20 名健康对照。
  • 刺激方案为每日一次、持续 10 天,强度 1.59 mA、每次 20 分钟,并在 4 个时间点评估语言/语义功能。

核心结论

  • 本研究旨在评估经颅直流电刺激对语义性痴呆语言/语义障碍的疗效,并探索刺激驱动改善的时间进程及反映神经可塑性的影像生物标志物。
  • 作者认为,若有效,该治疗将易于应用、成本低廉,并可在疾病进展导致疗效消失时重复使用。

研究设计与样本

  • 双盲、假刺激对照、随机临床试验(STIM-SD),计划纳入 60 例语义性痴呆患者,分为左侧阳极 tDCS 组(n=20)、右侧阴极 tDCS 组(n=20)和假刺激组(n=20)。
  • 另招募 20 名按年龄、性别和教育程度匹配的健康参与者,为语言/语义任务和影像指标提供常模值。
  • 刺激每日一次、持续 10 天,强度 1.59 mA、每次 20 分钟,通过 25 cm² 圆形电极(电流密度 0.06 mA/cm²)分别置于左、右前颞叶。
  • 在基线、10 次刺激后第 3 天、第 2 周和第 4 个月共 4 个时间点进行语言/语义评估;FDG-PET、静息态 fMRI、T1 加权成像和 DTI 在基线和第 2 周进行。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Semantic dementia is a neurodegenerative disease that primarily affects the left anterior temporal lobe, resulting in a gradual loss of conceptual knowledge. There is currently no validated treatment. Transcranial stimulation has provided evidence for long-lasting language effects presumably linked to stimulation-induced neuroplasticity in post-stroke aphasia. However, studies evaluating its effects in neurodegenerative diseases such as semantic dementia are still rare and evidence from double-blind, prospective, therapeutic trials is required. OBJECTIVE: The primary objective of the present clinical trial (STIM-SD) is to evaluate the therapeutic efficacy of a multiday transcranial direct current stimulation (tDCS) regime on language impairment in patients with semantic dementia. The study also explores the time course of potential tDCS-driven improvements and uses imaging biomarkers that could reflect stimulation-induced neuroplasticity. METHODS: This is a double-blind, sham-controlled, randomized study using transcranial Direct Current Stimulation (tDCS) applied daily for 10 days, and language/semantic and imaging assessments at four time points: baseline, 3 days, 2 weeks and 4 months after 10 stimulation sessions. Language/semantic assessments will be carried out at these same 4 time points. Fluorodeoxyglucose positron emission tomography (FDG-PET), resting-state functional magnetic resonance imaging (rs-fMRI), T1-weighted images and white matter diffusion tensor imaging (DTI) will be applied at baseline and at the 2-week time point. According to the principle of inter-hemispheric inhibition between left (language-related) and right homotopic regions we will use two stimulation modalities - left-anodal and right-cathodal tDCS over the anterior temporal lobes. Accordingly, the patient population (n = 60) will be subdivided into three subgroups: left-anodal tDCS (n = 20), right-cathodal tDCS (n = 20) and sham tDCS (n = 20). The stimulation will be sustained for 20 min at an intensity of 1.59 mA. It will be delivered through 25cm2-round stimulation electrodes (current density of 0.06 mA/cm2) placed over the left and right anterior temporal lobes for anodal and cathodal stimulation, respectively. A group of healthy participants (n = 20) matched by age, gender and education will also be recruited and tested to provide normative values for the language/semantic tasks and imaging measures. DISCUSSION: The aim of this study is to assess the efficacy of tDCS for language/semantic disorders in semantic dementia. A potential treatment would be easily applicable, inexpensive, and renewable when therapeutic effects disappear due to disease progression. TRIAL REGISTRATION: ClinicalTrials.gov NCT03481933. Registered on March 2018.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Sanches C, Levy R, Benisty S, et al. Testing the therapeutic effects of transcranial direct current stimulation (tDCS) in semantic dementia: a double blind, sham controlled, randomized clinical trial. Trials. 2019. PMID: 31747967. doi:10.1186/s13063-019-3613-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。